NT
Insider selling
Nancy Thornberry sold $262K of Denali Therapeutics Inc. (DNLI) stock
Nancy Thornberry, Dir of Denali Therapeutics Inc. (DNLI), sold 11,439 shares of DNLI stock worth $262K, per an SEC Form 4 filed Sep 4, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 2, 2026, 2 days before it was made public.
DNLI has moved -10.4% since the trade date, from $22.85 to $20.47 (Sep 21, 2026 close).
- Traded
- Sep 2, 2026
- Disclosed
- Sep 4, 2026
- Filing delay
- 2 days
- Price since
- -10.4%
- Role
- Dir
- Source
- SEC Form 4
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.